Stockreport

Biopharmaceutical Fermentation Systems Industry Report 2024 - Upstream Products Segment is Forecast to Reach US$6.5 Billion by 2030 with a CAGR of a 3.7% [Yahoo! Finance]

Becton, Dickinson and Company  (BDX) 
Last becton, dickinson and company earnings: 2/6 06:00 am Check Earnings Report
US:NYSE Investor Relations: investors.bd.com
PDF investment in biopharmaceutical R&D, and advancements in fermentation technologies. The growing adoption of single-use technologies, which offer greater flexibility and [Read more]